PRESS RELEASE published on 01/30/2025 at 18:00, 1 year 6 months ago THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2024 AND PRESENTS ITS PROGRESS REPORT Theranexus announces cash position of €4.0 M as of 29 January 2025, strengthening financial outlook. Biopharmaceutical company progressing on rare neurological disease treatments, including Niemann-Pick and Gaucher diseases Cash Position Biopharmaceutical Financial Outlook Theranexus Neurological Diseases
BRIEF published on 01/23/2025 at 18:20, 1 year 6 months ago Theranexus Unveils 2025 Financial Calendar Financial Calendar Biopharmaceutical Theranexus Neurological Diseases 2025 Schedule
PRESS RELEASE published on 01/23/2025 at 18:15, 1 year 6 months ago THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025 Theranexus, a biopharmaceutical company in rare neurological disease treatment, announces its 2025 financial communication agenda for Euronext market. Dates subject to change Euronext Biopharmaceutical Financial Communication Theranexus Neurological Diseases
BRIEF published on 01/23/2025 at 18:05, 1 year 6 months ago Theranexus Announces its Financial Agenda for 2025 Euronext Paris Financial Agenda Theranexus Financial Publications Neurological Diseases
BRIEF published on 01/16/2025 at 18:05, 1 year 6 months ago Theranexus: Monthly update of voting rights and shares Voting Rights Actions Stock Market Biopharmaceutical Theranexus
BRIEF published on 01/09/2025 at 18:05, 1 year 6 months ago Theranexus Publishes its Letter to Shareholders Financial Outlook Theranexus Rare Neurological Diseases Letter To Shareholders Innovative Platform
PRESS RELEASE published on 01/09/2025 at 18:00, 1 year 6 months ago THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS Theranexus, an innovative biopharmaceutical company, announces the publication of its letter to shareholders. Shareholders can download the newsletter from the company website Shareholders Biopharmaceutical Newsletter Theranexus Neurological Diseases
BRIEF published on 12/17/2024 at 18:20, 1 year 7 months ago Theranexus optimizes its cash flow and extends its financial horizon Treasury Funding License Agreement Theranexus Batten Disease
PRESS RELEASE published on 12/17/2024 at 18:15, 1 year 7 months ago THERANEXUS PRESENTS AN UPDATE OF ITS CASH POSITION AND FINANCING HORIZON Theranexus presents an update of its cash position and cash flow horizon, expecting improvement through upcoming payments and restructuring agreement with banking partners Cash Position Cash Flow Financial Debt Theranexus Banking Partners
BRIEF published on 12/17/2024 at 18:05, 1 year 7 months ago License agreement between Theranexus and Exeltis for TX01 Rare Diseases License Agreement Theranexus Exeltis TX01
Published on 08/01/2026 at 01:20, 2 days 6 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 6 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 6 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 2 days 8 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/03/2026 at 07:00, 27 minutes ago Sandoz takes further steps to resolve legacy US generic medicine litigation
Published on 08/03/2026 at 07:00, 27 minutes ago Stabilus SE: Adjusted EBIT margin increased in Q3 FY2026 despite a decline in revenue – sale of Fabreeka and Tech Products completed and net debt further reduced
Published on 08/03/2026 at 07:00, 27 minutes ago AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland AG continues to grow and outperforms the Swiss hotel market in the first half of 2026
Published on 08/03/2026 at 06:45, 42 minutes ago HDBank secures record international syndicated social loan in Vietnam
Published on 08/03/2026 at 06:30, 57 minutes ago HDBank posts 31% rise in first-half profit, assets exceed VND1 quadrillion
Published on 08/03/2026 at 07:00, 27 minutes ago BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 07/31/2026 at 21:00, 2 days 10 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 12 hours ago Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:13, 2 days 12 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
